ProBio is a global contract development and manufacturing (CDMO) organization, which aims to accelerate the manufacturing of life-changing drugs, discover novel therapeutic targets, and develop innovative therapeutic approaches to manufacture best-in-class DNA, RNA, and protein-based therapeutics. As a global partner, ProBio brings together multi-disciplinary expertise to accelerate the manufacturing of advanced therapies, including biologics, protein and mRNA vaccines, viral vectors, antibody-drug conjugates and drug discovery services. We aid you in realizing the potential of your breakthrough discovery to treat diseases and improve lives. Let us accelerate your path to market with the greatest chance of success!
Company Details
- Employees
- 211
- Founded
- -
- Address
- Building 9, 311 Pennington Rocky Hill Rd, Pennington,new Jersey 08854,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.probiocdmo.com/
- Keywords
- CDMO, Advanced Therapies, Biologics Development, Outsource Manufacturing, Cell and Gene Therapies, Cell Therapy, Viral Vector Manufacturing, Protein Antibody Drug Development, Protein Engineering, Gene Therapies, AAV, Plasmid DNA.
- HQ
- Pennington, New Jersey
Probio Questions
Probio's website is http://www.probiocdmo.com/
Probio's LinkedIn profile is https://www.linkedin.com/company/probio-cdmo
Probio has
211 employees.
View email and phone details for 211
employees at Probio.
Probio's industry is
Biotechnology Research
Probio's top competitors are
Genscript,
Abbvie,
Catalent,
Legend Biotech,
Regeneron,
Probiopharm,
Gsk,
Probio Corporation,
Wuxi Biologics,
Probio Pharmaceutical.
Probio's categories are Biotechnology Research
Probio's founding year is 2020
